Citation: N. Brouwenstijn et al., MHC class I molecules can direct proteolytic cleavage of antigenic precursors in the endoplasmic reticulum, IMMUNITY, 15(1), 2001, pp. 95-104
Authors:
Choi, EY
Yoshimura, Y
Christianson, GJ
Sproule, TJ
Malarkannan, S
Shastri, N
Joyce, S
Roopenian, DC
Citation: Ey. Choi et al., Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: The H60 histocompatibility antigen dominates over allothers, J IMMUNOL, 166(7), 2001, pp. 4370-4379
Authors:
Mendoza, LM
Villaflor, G
Eden, P
Roopenian, D
Shastri, N
Citation: Lm. Mendoza et al., Distinguishing self from nonself: Immunogenicity of the murine H47 locus is determined by a single amino acid substitution in an unusual peptide, J IMMUNOL, 166(7), 2001, pp. 4438-4445
Citation: K. Frauwirth et N. Shastri, Introducing endogenous antigens into the major histocompatibility complex (MHC) class II presentation pathway. Both Ii mediated inhibition and enhancement of endogenous peptide/MHC class II presentation require the same Ii domains, IMMUNOLOGY, 102(4), 2001, pp. 405-415
Citation: K. Frauwirth et N. Shastri, Mutation of the invariant chain transmembrane region inhibits Ii degradation, prolongs association with MHC class II, and selectively disrupts antigen presentation, CELL IMMUN, 209(2), 2001, pp. 97-108
Authors:
Diefenbach, A
Jamieson, AM
Liu, SD
Shastri, N
Raulet, DH
Citation: A. Diefenbach et al., Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages, NAT IMMUNOL, 1(2), 2000, pp. 119-126
Authors:
Malarkannan, S
Horng, T
Eden, P
Gonzalez, F
Shih, P
Brouwenstijn, N
Klinge, H
Christianson, G
Roopenian, D
Shastri, N
Citation: S. Malarkannan et al., Differences that matter: Major cytotoxic T cell-stimulating minor histocompatibility antigens, IMMUNITY, 13(3), 2000, pp. 333-344
Citation: Dj. Campbell et al., Bacterial proteins can be processed by macrophages in a transporter associated with antigen processing-independent, cysteine protease-dependent manner for presentation by MHC class I molecules, J IMMUNOL, 164(1), 2000, pp. 168-175
Authors:
Schwarz, K
van den Broek, M
de Giuli, R
Seelentag, WW
Shastri, N
Groettrup, M
Citation: K. Schwarz et al., The use of LCMV-specific T cell hybridomas for the quantitative analysis of MHC class I restricted antigen presentation, J IMMUNOL M, 237(1-2), 2000, pp. 199-202
Authors:
Wong, FS
Karttunen, J
Dumont, C
Wen, L
Visintin, I
Pilip, IM
Shastri, N
Pamer, EG
Janeway, CA
Citation: Fs. Wong et al., Identification of an MHC class I-restricted autoantigen in type 1 diabetesby screening an organ-specific cDNA library, NAT MED, 5(9), 1999, pp. 1026-1031
Authors:
Paz, P
Brouwenstijn, N
Perry, R
Shastri, N
Citation: P. Paz et al., Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER, IMMUNITY, 11(2), 1999, pp. 241-251
Authors:
Malarkannan, S
Horng, T
Shih, PP
Schwab, S
Shastri, N
Citation: S. Malarkannan et al., Presentation of out-of-frame peptide MHC class I complexes by a novel translation initiation mechanism, IMMUNITY, 10(6), 1999, pp. 681-690
Authors:
Coppola, MA
Flano, E
Nguyen, P
Hardy, CL
Cardin, RD
Shastri, N
Woodland, DL
Blackman, MA
Citation: Ma. Coppola et al., Apparent MHC-independent stimulation of CD8(+) T cells in vivo during latent murine gammaherpesvirus infection, J IMMUNOL, 163(3), 1999, pp. 1481-1489
Citation: T. Serwold et N. Shastri, Specific proteolytic cleavages limit the diversity of the pool of peptidesavailable to MHC class I molecules in living cells, J IMMUNOL, 162(8), 1999, pp. 4712-4719
Authors:
Zuberi, AR
Christianson, GJ
Mendoza, LM
Shastri, N
Roopenian, DC
Citation: Ar. Zuberi et al., Positional cloning and molecular characterization of an immunodominant cytotoxic determinant of the mouse H3 minor histocompatibility complex, IMMUNITY, 9(5), 1998, pp. 687-698